Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

advertisement

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

Colliers arranges $5.8M sale of two-building portfolio in Lebanon

By Emily Bader
February 26, 2015 10:59 AM

CONTINUE READING

JLL inks two deals at Class A office building in Morristown

By Emily Bader
February 26, 2015 12:52 PM

CONTINUE READING

Hampshire sells South Hackensack industrial warehouse to Park Ave. Motor Corp.

By Emily Bader
February 26, 2015 01:09 PM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

Commercial insurance firm leases 51K sq. ft. at Whippany office park

By February 27, 2015 11:01 AM

CONTINUE READING

Engineering and construction firm leases Mount Laurel office suite

By Eric Strauss
February 27, 2015 12:35 PM

CONTINUE READING

advertisement

Orbcomm continuing services relationship with Japanese equipment maker

By Eric Strauss
February 27, 2015 10:52 AM

CONTINUE READING

Monmouth REIT pays $30.6M for Florida building

By Eric Strauss
February 26, 2015 04:21 PM

CONTINUE READING

Roselle Savings Bank names new EVP, COO

By Eric Strauss
February 26, 2015 03:30 PM

CONTINUE READING

Larken Associates acquires Pa. apartment community, expands Lehigh Valley portfolio

By Emily Bader
February 26, 2015 04:28 PM

CONTINUE READING

New York REIT purchases Matawan apartment complex for $31M

By Emily Bader
February 26, 2015 11:13 AM

CONTINUE READING

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:

Notes from Cambridge

By

Back to Top Comments Email Print

Latest News

advertisement
Amgen's Kendall Square location.
Amgen's Kendall Square location. - ()

Over the weekend I took a trip up to Cape Ann in Massachusetts. Along the way, my wife and I stopped to see a movie that was only showing in two area theaters – one in Cambridge and one in Boston.

We chose the Cambridge theater, which was located in Kendall Square. The name "Kendall Square" didn't mean anything to me. I figured it was some sort of shopping center.

When we got there, we had a couple of hours before the movie, so we thought we'd pick up a few things at a drug store and then grab lunch.

I searched for "drug store" on my phone, and found one just a few hundred yards away. We followed the map, but soon found ourselves in the middle of an office park. When I read the complex's business directory, I realized the problem. Google hadn't taken us to a drug store, it had taken us to a hub of drug companies. Kendall Square, it turns out, is home to dozens of pharma and biotech firms, including Novartis, Genzyme and Amgen.

Cambridge, of course, is also home to Harvard University and the Massachusetts Institute of Technology. Though I hadn't intended to take a tour of the Bay State's biopharmaceutical corridor, the stop at Kendall Square reminded me of a conversation I had last week with BioNJ President Debbie Hart.

"If we have Big Pharma setting up shop in the Cambridge area, clearly that's a function of the academic environment up there and the synergy of industry and academia working together," she said.

Hart said New Jersey could do more to foster collaboration between the state's biopharma companies and higher ed institutions.

The above comment is from a story I wrote about a new BioNJ survey of the state's biotechnology industry. The report shows positive numbers, but also calls on the state to do more to support the industry.

It's clear the greater Boston area has a strong core from which to grow its life sciences sector. New Jersey, too, has a quiver full of assets, both historical and geographical. But with such stiff competition between life sciences hubs, it seems one thing New Jersey doesn't have is the luxury of resting on its laurels.

Share This Story On:
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy
advertisement
follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement
Notes from Cambridge | NJBIZ

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top